Skip to Navigation

History

home > Company > History
  • 2020
    • 06. License out of the new drug candidates for the STAT3 next generation
      targeted agents (ST-2286)
    • 06. Completed phase 1 clinical trial for atopic treatment
  • 2019
    • 09. Gout treatment third party license out (Simcere)
  • 2018
    • 08. Third-party license out of atopy treatment (Leo Pharma.)
    • 07. A*STAR (Agency of Science, Technology and Research)
      affiliated research institutes (SRIS, SIgN, GIS, IMB) and
      Singapore National Skin Center (NSC) joint research start
  • 2017
    • 04. Licensed out of preclinical candidates for atopy treatment (JW Pharmaceutical)
  • 2016
    • 08. Completed phase 2a of gout treatment
  • 2014
    • 05. Entry into phase II clinical study of anti-gout drug
  • 2013
    • 12. Completion of phase I clinical study of anti-gout drug
  • 2012
    • 04. International Symposium in commemoration of 20th
      Anniversary
      (“Challenge to Innovative Research & Development in
      Cancer Therapy”)
    • 02. Relocation of research institute (DRC, Natural science
      campus in Sungkyunkwan University)
  • 2010
    • 10. Foundation of Clinical Research Center
    • 03. License-out of drug candidates for anti-gout disease
  • 2008
    • 10. Publication of company history in commemoration of
      15th Anniversary
  • 2002
    • 04. International Symposium in commemoration of 10th
      Anniversary
  • 2001
    • 03. License-out of anti-breast Cancer and anti-IBS
      (Irritable Bowel Syndrome) drug candidates
  • 1992
    • 01. Establishment of C&C Research Laboratories (1992. 01. 31)